                                                                                                                                     I




                                  113TH CONGRESS
                                     1ST SESSION                        H. R. 1102
                                  To amend part D of title XVIII of the Social Security Act to require
                                     the Secretary of Health and Human Services to negotiate covered part
                                     D drug prices on behalf of Medicare beneficiaries.




                                                IN THE HOUSE OF REPRESENTATIVES
                                                                 MARCH 12, 2013
                                  Mr. WELCH (for himself, Ms. CASTOR of Florida, Mr. CICILLINE, Mr. CON-
                                      YERS, Mr. ELLISON, Mr. CLAY, Ms. MOORE, Ms. SLAUGHTER, Mr. YAR-
                                      MUTH, Mr. MICHAUD, and Ms. SCHAKOWSKY) introduced the following
                                      bill; which was referred to the Committee on Energy and Commerce, and
                                      in addition to the Committee on Ways and Means, for a period to be sub-
                                      sequently determined by the Speaker, in each case for consideration of
                                      such provisions as fall within the jurisdiction of the committee concerned




                                                                            A BILL
                                  To amend part D of title XVIII of the Social Security
                                     Act to require the Secretary of Health and Human Serv-
                                     ices to negotiate covered part D drug prices on behalf
                                     of Medicare beneficiaries.
                                    1              Be it enacted by the Senate and House of Representa-
                                    2 tives of the United States of America in Congress assembled,
                                    3     SECTION 1. SHORT TITLE.
                                    4              This Act may be cited as the ‘‘Medicare Prescription




                                    5 Drug Price Negotiation Act of 2013’’.
                                    1     SEC. 2. NEGOTIATION OF LOWER COVERED PART D DRUG   2
                                    2                             PRICES ON BEHALF OF MEDICARE BENE-
                                    3                             FICIARIES.
                                    4              (a) NEGOTIATION                   BY      SECRETARY.—Section 1860D–
                                    5 11 of the Social Security Act (42 U.S.C. 1395w–111) is
                                    6 amended by striking subsection (i) (relating to noninter-
                                    7 ference) and inserting the following:
                                    8              ‘‘(i) NEGOTIATION OF LOWER DRUG PRICES.—
                                    9                        ‘‘(1) IN       GENERAL.—Notwithstanding                                 any other
                                  10               provision of law, the Secretary shall negotiate with
                                  11               pharmaceutical manufacturers the prices (including
                                  12               discounts, rebates, and other price concessions) that
                                  13               may be charged to PDP sponsors and MA organiza-
                                  14               tions for covered part D drugs for part D eligible in-
                                  15               dividuals who are enrolled under a prescription drug
                                  16               plan or under an MA–PD plan.
                                  17                         ‘‘(2)         NO           CHANGE                 IN            RULES        FOR
                                  18               FORMULARIES.—
                                  19                                  ‘‘(A) IN       GENERAL.—Nothing                         in paragraph
                                  20                         (1) shall be construed to authorize the Sec-
                                  21                         retary to establish or require a particular for-
                                  22                         mulary.
                                  23                                  ‘‘(B) CONSTRUCTION.—Subparagraph (A)
                                  24                         shall not be construed as affecting the Sec-




                                  25                         retary’s authority to ensure appropriate and
                                  26                         adequate access to covered part D drugs under
                                              •HR 1102 IH

                                                                                             3
                                    1                        prescription drug plans and under MA–PD
                                    2                        plans, including compliance of such plans with
                                    3                        formulary requirements under section 1860D–
                                    4                        4(b)(3).
                                    5                        ‘‘(3) CONSTRUCTION.—Nothing in this sub-
                                    6              section shall be construed as preventing the sponsor
                                    7              of a prescription drug plan, or an organization offer-
                                    8              ing an MA–PD plan, from obtaining a discount or
                                    9              reduction of the price for a covered part D drug
                                  10               below the price negotiated under paragraph (1).
                                  11                         ‘‘(4) SEMI-ANNUAL                    REPORTS TO CONGRESS.—
                                  12               Not later than June 1, 2014, and every 6 months
                                  13               thereafter, the Secretary shall submit to the Com-
                                  14               mittees on Ways and Means, Energy and Commerce,
                                  15               and Oversight and Government Reform of the House
                                  16               of Representatives and the Committee on Finance of
                                  17               the Senate a report on negotiations conducted by the
                                  18               Secretary to achieve lower prices for Medicare bene-
                                  19               ficiaries, and the prices and price discounts achieved
                                  20               by the Secretary as a result of such negotiations.’’.
                                  21               (b) EFFECTIVE DATE.—The amendment made by
                                  22 subsection (a) shall take effect on the date of the enact-
                                  23 ment of this Act and shall first apply to negotiations and




                                  24 prices for plan years beginning on January 1, 2014.
                                                                                             Æ

                                              •HR 1102 IH

